Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Single-arm Study of ON 01910.Na by 2-hr Infusion in Patients With Recurring Platinum-resistant Ovarian Cancer

NCT00856791 is registered in ClinicalTrials.gov with Traws Pharma, Inc. as lead sponsor.

NCT NCT00856791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00856791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Single-arm Study of ON 01910.Na by 2-hr Infusion in Patients With Recurring Platinum-resistant Ovarian Cancer
Lead sponsor
Traws Pharma, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2009
Completion date
July 31, 2011
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer